Brookstone Capital Management Ark Genomic Revolution ETF (De Transaction History

Brookstone Capital Management

$5.98 Billion
Q4 2024

A detailed history of Brookstone Capital Management transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Brookstone Capital Management holds 58,467 shares of ARKG stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

58,467

Previous 66,484 12.06%

Holding current value

$1.47 Million

Previous $1.7 Million 19.11%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$22.66 - $27.11 $181,665 - $217,340	-8,017 Reduced 12.06%	58,467 $1.38 Million
Q3 2024 Oct 08, 2024	SELL	$22.89 - $27.41 $136,287 - $163,199	-5,954 Reduced 8.22%	66,484 $1.7 Million
Q2 2024 Jul 18, 2024	SELL	$23.01 - $28.35 $189,924 - $234,000	-8,254 Reduced 10.23%	72,438 $1.7 Million
Q1 2024 Apr 15, 2024	BUY	$27.9 - $32.96 $54,656 - $64,568	1,959 Added 2.49%	80,692 $2.32 Million
Q4 2023 Jan 11, 2024	SELL	$22.24 - $34.25 $258,517 - $398,122	-11,624 Reduced 12.86%	78,733 $2.58 Million
Q3 2023 Oct 20, 2023	SELL	$27.6 - $38.18 $265,732 - $367,597	-9,628 Reduced 9.63%	90,357 $2.52 Million
Q2 2023 Jul 11, 2023	SELL	$28.26 - $35.21 $126,689 - $157,846	-4,483 Reduced 4.29%	99,985 $3.41 Million
Q1 2023 Apr 18, 2023	SELL	$27.46 - $36.49 $101,904 - $135,414	-3,711 Reduced 3.43%	104,468 $3.14 Million
Q4 2022 Jan 09, 2023	SELL	$27.08 - $36.23 $1.1 Million - $1.48 Million	-40,792 Reduced 27.38%	108,179 $0
Q3 2022 Oct 13, 2022	SELL	$31.57 - $42.39 $694,603 - $932,664	-22,002 Reduced 12.87%	148,971 $4.76 Million
Q2 2022 Jul 11, 2022	BUY	$27.2 - $48.94 $182,185 - $327,800	6,698 Added 4.08%	170,973 $6.41 Million
Q1 2022 Apr 12, 2022	SELL	$38.15 - $63.26 $753,462 - $1.25 Million	-19,750 Reduced 10.73%	164,275 $7.01 Million
Q4 2021 Jan 11, 2022	SELL	$58.39 - $78.64 $864,580 - $1.16 Million	-14,807 Reduced 7.45%	184,025 $9.98 Million
Q3 2021 Nov 03, 2021	SELL	$73.87 - $92.86 $628,929 - $790,610	-8,514 Reduced 4.11%	198,832 $14.6 Million
Q2 2021 Jul 14, 2021	BUY	$73.64 - $93.1 $438,673 - $554,596	5,957 Added 2.96%	207,346 $17.9 Million
Q1 2021 Apr 16, 2021	BUY	$81.74 - $112.47 $3.85 Million - $5.29 Million	47,053 Added 30.49%	201,389 $17.9 Million
Q4 2020 Jan 13, 2021	BUY	$63.39 - $105.53 $2.89 Million - $4.82 Million	45,628 Added 41.97%	154,336 $14.4 Million
Q3 2020 Oct 13, 2020	BUY	$53.19 - $64.24 $2.56 Million - $3.09 Million	48,098 Added 79.36%	108,708 $6.93 Million
Q2 2020 Jul 21, 2020	BUY	$29.13 - $53.08 $981,622 - $1.79 Million	33,698 Added 125.22%	60,610 $3.16 Million
Q1 2020 Apr 14, 2020	BUY	$24.5 - $37.69 $228,609 - $351,685	9,331 Added 53.07%	26,912 $842,000
Q4 2019 Jan 29, 2020	BUY	$27.95 - $36.43 $206,466 - $269,108	7,387 Added 72.46%	17,581 $589,000
Q3 2019 Oct 18, 2019	BUY	$29.35 - $35.25 $299,193 - $359,338	10,194 New	10,194 $301,000
Q4 2018 Feb 06, 2019	SELL	$22.36 - $32.61 $614,989 - $896,905	-27,504 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$28.65 - $34.45 $787,989 - $947,512	27,504 New	27,504 $919,000

Others Institutions Holding ARKG

# of Institutions

284

Shares Held

23.3M

Call Options Held

2.91M

Put Options Held

2.5M

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Ark Genomic Revolution ETF (De Transaction History